145 related articles for article (PubMed ID: 6547486)
1. Hypouricemic action of diflunisal in gouty patients: in vitro and in vivo studies.
Ferraccioli G; Spisni A; Ambanelli U
J Rheumatol; 1984 Jun; 11(3):330-2. PubMed ID: 6547486
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the urate lowering effects of allopurinol and diflunisal.
Emmerson BT; Hazelton RA; Whyte IM
J Rheumatol; 1987 Apr; 14(2):335-7. PubMed ID: 3599002
[TBL] [Abstract][Full Text] [Related]
3. [Hypouricemic effect of diflunisal in patients with gout].
Pavelka K; Vácha J; Kohoutová B; Trnavský K
Cas Lek Cesk; 1986 Nov; 125(46):1409-11. PubMed ID: 3815465
[No Abstract] [Full Text] [Related]
4. [The uric acid-lowering effect of diflunisal].
Fasching U
Wien Klin Wochenschr; 1987 Nov; 99(22):791-3. PubMed ID: 3433782
[TBL] [Abstract][Full Text] [Related]
5. Hypouricemic action of diflunisal in gouty patients.
Pavelka K; Vacha J; Kohoutova B; Trnavsky K
Clin Rheumatol; 1986 Jun; 5(2):271-2. PubMed ID: 3731723
[No Abstract] [Full Text] [Related]
6. Persistent hypouricemic effect of longterm diflunisal administration.
van Loenhout JW; van de Putte LB; Gribnau FW; van Ginneken CA
J Rheumatol; 1981; 8(4):639-42. PubMed ID: 7299765
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
Delbarre F; Saporta L; de Géry A; Jabre E
Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
[No Abstract] [Full Text] [Related]
9. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
Royer R; Vindel J; Lamarche M; Kissel P
Presse Med (1893); 1968 Dec; 76(49):2325-7. PubMed ID: 5737250
[No Abstract] [Full Text] [Related]
10. In vitro xanthine oxidase inhibitory and in vivo hypouricemic activity of herbal coded formulation (Gouticin).
Akram M; Usmanghani K; Ahmed I; Azhar I; Hamid A
Pak J Pharm Sci; 2014 May; 27(3):541-50. PubMed ID: 24811815
[TBL] [Abstract][Full Text] [Related]
11. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
Chalmers RA; Krömer H; Scott JT; Watts RW
Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
[No Abstract] [Full Text] [Related]
13. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhu JX; Wang Y; Kong LD; Yang C; Zhang X
J Ethnopharmacol; 2004 Jul; 93(1):133-40. PubMed ID: 15182918
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology of hypouricemic effect of benzbromarone.
Sinclair DS; Fox IH
J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
[TBL] [Abstract][Full Text] [Related]
15. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhao X; Zhu JX; Mo SF; Pan Y; Kong LD
J Ethnopharmacol; 2006 Feb; 103(3):357-65. PubMed ID: 16182482
[TBL] [Abstract][Full Text] [Related]
16. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
[No Abstract] [Full Text] [Related]
18. The dual actions of morin (3,5,7,2',4'-pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity.
Yu Z; Fong WP; Cheng CH
J Pharmacol Exp Ther; 2006 Jan; 316(1):169-75. PubMed ID: 16169936
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of antihyperuricemic effect of Phyllanthus niruri and its lignan constituents.
Murugaiyah V; Chan KL
J Ethnopharmacol; 2009 Jul; 124(2):233-9. PubMed ID: 19397979
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
